The company's website paired their "E-Rimonabant HelloCig E-Liquid” with an image of an Acomplia container and tablets. Acomplia happens to be a brand name for rimonabant. Erectile dysfunction ...

But European regulators approved rimonabant, marketed under the name Acomplia, in 2006 based on extensive clinical trials. Two years later, European regulators recommended the suspension of ...

which partly stems from experience with an earlier Sanofi weight-loss drug called Acomplia/Zimulti (rimonabant). That was approved in Europe in 2006, but withdrawn from sale two years later after ...

Shares of the Paris-based drug giant have fallen about 9% since July 2006 because of concerns about generic competition and delays in the launch of its anti-obesity product, Acomplia. But a rich ...

Heightened suicide risks have caused regulators to issue strong warnings on obesity drugs in the past, with Sanofi's Acomplia, which never won U.S. approval, being withdrawn in Europe in 2008 ...

Safety issues that led to the withdrawals of the cannabinoid receptor antagonist Acomplia (rimonabant) and, before that, appetite suppressant Redux (dexfenfluramine), mean that novel products are ...

And on the obesity end, a new drug called Acomplia, which cuts appetite and curbs the craving for nicotine, is also expected to gain FDA approval. "Both agents will add to our ever expanding war ...

This culminated in the approval of Sanofi’s Acomplia (rimonabant) in 2006 for the treatment of obesity, and the large number of clinical trials in non-alcoholic steatohepatitis (NASH), pre ...

He said Nice had conducted an impressive assessment of the drug, which is sold under the trade name Acomplia. Dr Haslam said: "The Nice review is a very robust, very detailed analysis of all of ...